Increased Use Of Tranexamic Acid To Prevent Postpartum Hemorrhage In The Global Hematology Drugs Market
Companies Included: Novo Nordisk A/S, Shire Plc., Bayer AG, Daiichi Sankyo Company, Limited, Biogen Inc., Pfizer Inc.
(EMAILWIRE.COM, August 31, 2018 ) Hematology drugs market offers drugs, blood and blood products that are used for the treatment of diseases such as rare genetic disorders, anemia, and conditions related to sickle cell disease and other related diseases. Some of the major hematology drugs include Albumin, Epoetin, Zoladex, and Hyskon.
Order report at:
https://www.thebusinessresearchcompany.com/report/hematology-drugs-global-market-report-2018
The global hematology drugs market has been growing in the past years with a CAGR of almost 6%. The year 2017 recorded high growth in this market with a net market value more than 21% higher than that of 2013, as per TBRC’s in-house consultants.
TBRC’s latest report show the historic and future trends in the market for each year with sourced reasons to support the growth claims.
The report also shows the global hematology drugs market to grow at a higher CAGR by 2021 as compared to 2017, along with geographies best suited for investments with highest return rate.
Download sample report at:
https://www.thebusinessresearchcompany.com/sample.aspx?id=275&type=smp
Tranexamic acid is increasingly being used to prevent postpartum hemorrhage (blood loss of over 500 ml or 1,000 ml within 24 hours of childbirth) due to its cheap price and wide availability. Tranexamic acid is an antifibrinolytic drug that helps in reducing bleeding in surgical and trauma patients, including women with postpartum hemorrhage. In April 2017, WOMAN (World Maternal Antifibrinolytic), an international, randomized, double-blind, placebo-controlled trial including over 20,000 women from 193 hospitals in 21 countries, found that using tranexamic acid within three hours of childbirth lowered death from bleeding by 31% and reduced the need for laparotomy (emergency bleeding control surgery) by 36%.
Request for discount:
https://www.thebusinessresearchcompany.com/sample.aspx?id=275&type=discount
Companies included in the report are Novo Nordisk A/S, Shire Plc., Bayer AG, Daiichi Sankyo Company, Limited, Biogen Inc., and Pfizer Inc.
About The Business Research Company:
The Business Research Company is a Business Intelligence Company which excels in company, market and consumer research. It has offices in the UK, the US and India and a network of trained researchers in 15 countries globally.
Contact Information
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow us on LinkedIn: https://in.linkedin.com/company/the-business-research-company
Order report at:
https://www.thebusinessresearchcompany.com/report/hematology-drugs-global-market-report-2018
The global hematology drugs market has been growing in the past years with a CAGR of almost 6%. The year 2017 recorded high growth in this market with a net market value more than 21% higher than that of 2013, as per TBRC’s in-house consultants.
TBRC’s latest report show the historic and future trends in the market for each year with sourced reasons to support the growth claims.
The report also shows the global hematology drugs market to grow at a higher CAGR by 2021 as compared to 2017, along with geographies best suited for investments with highest return rate.
Download sample report at:
https://www.thebusinessresearchcompany.com/sample.aspx?id=275&type=smp
Tranexamic acid is increasingly being used to prevent postpartum hemorrhage (blood loss of over 500 ml or 1,000 ml within 24 hours of childbirth) due to its cheap price and wide availability. Tranexamic acid is an antifibrinolytic drug that helps in reducing bleeding in surgical and trauma patients, including women with postpartum hemorrhage. In April 2017, WOMAN (World Maternal Antifibrinolytic), an international, randomized, double-blind, placebo-controlled trial including over 20,000 women from 193 hospitals in 21 countries, found that using tranexamic acid within three hours of childbirth lowered death from bleeding by 31% and reduced the need for laparotomy (emergency bleeding control surgery) by 36%.
Request for discount:
https://www.thebusinessresearchcompany.com/sample.aspx?id=275&type=discount
Companies included in the report are Novo Nordisk A/S, Shire Plc., Bayer AG, Daiichi Sankyo Company, Limited, Biogen Inc., and Pfizer Inc.
About The Business Research Company:
The Business Research Company is a Business Intelligence Company which excels in company, market and consumer research. It has offices in the UK, the US and India and a network of trained researchers in 15 countries globally.
Contact Information
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow us on LinkedIn: https://in.linkedin.com/company/the-business-research-company
Contact Information:
The Business Research Company
Marketing TBRC
Tel: +91 8897263534
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
The Business Research Company
Marketing TBRC
Tel: +91 8897263534
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results